Literature DB >> 5066513

Cobra venom-induced hemolysis. Activity levels in sera of patients with neoplastic and other diseases.

M Brai, A G Osler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5066513      PMCID: PMC2139283          DOI: 10.1084/jem.136.4.950

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


× No keyword cloud information.
  7 in total

1.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

2.  The biologic activities of guinea pig antibodies. I. Separation of gamma1 and gamma2 immunoglobulins and their participation in allergic reactions of the immediate type.

Authors:  B Oliveira; A G Osler; R P Siraganian; A L Sandberg
Journal:  J Immunol       Date:  1970-02       Impact factor: 5.422

3.  The fixation of guinea pig complement by gamma 1 and gamma 2 immunoglobulins.

Authors:  A G Osler; B Oliveira; H S Shin; A L Sandberg
Journal:  J Immunol       Date:  1969-01       Impact factor: 5.422

4.  Specific hemagglutinin and a modulator of complement in cockroach hemolymph.

Authors:  R S Anderson; N K Day; R A Good
Journal:  Infect Immun       Date:  1972-01       Impact factor: 3.441

5.  Dual pathways of complement interaction with guinea pig immunoglobulins.

Authors:  A L Sandberg; A G Osler
Journal:  J Immunol       Date:  1971-11       Impact factor: 5.422

6.  Studies of the C3 shunt activation in cobra venom induced lysis of unsensitized erythrocytes.

Authors:  M Brai; A G Osler
Journal:  Proc Soc Exp Biol Med       Date:  1972-07

7.  Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components.

Authors:  H Gewurz; H S Shin; S E Mergenhagen
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

  7 in total
  4 in total

1.  Alternative complement pathway: activity levels in allogeneic pregnancy.

Authors:  M Brai; G Tolone; A Magro; H Waks; M Brai
Journal:  Experientia       Date:  1976-12-15

2.  Combined homozygous factor H and heterozygous C2 deficiency in an Italian family.

Authors:  M Brai; G Misiano; S Maringhini; I Cutaja; G Hauptmann
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

3.  C3 proactivator (C3PA) as an acute phase reactant.

Authors:  M Schutte; R DiCamelli; P Murphy; M Sadove; H Gewurz
Journal:  Clin Exp Immunol       Date:  1974-10       Impact factor: 4.330

4.  The heterocytotoxicity of human serum. III. Studies of the serum levels and distribution of activity in human populations.

Authors:  G Glumac; A Mates; D Eidinger
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.